Login / Signup

Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa.

Martie van der WaltSikhethiwe MasukuSonja BothaTshifhiwa NkwenikaKaren H Keddy
Published in: PloS one (2020)
DR-TB treatment should be delayed until after the first trimester. Routine pharmacovigilance surveillance integrated antenatal and delivery services with an integrated record of DR-TB treatment during pregnancy is recommended. Prospective studies using standardised case record forms for DR-TB treatment for pregnant women could provide more insight on the effect of DR-TB treatment on the birth outcome.
Keyphrases
  • pregnant women
  • mycobacterium tuberculosis
  • south africa
  • combination therapy
  • editorial comment
  • hiv infected
  • preterm birth
  • clinical practice
  • adverse drug
  • electronic health record